Literature DB >> 18227387

Identification of target domains of the cardiac ryanodine receptor to correct channel disorder in failing hearts.

Takeshi Yamamoto1, Masafumi Yano, XiaoJuan Xu, Hitoshi Uchinoumi, Hiroki Tateishi, Mamoru Mochizuki, Tetsuro Oda, Shigeki Kobayashi, Noriaki Ikemoto, Masunori Matsuzaki.   

Abstract

BACKGROUND: We previously demonstrated that defective interdomain interaction between N-terminal (0 to 600) and central regions (2000 to 2500) of ryanodine receptor 2 (RyR2) induces Ca2+ leak in failing hearts and that K201 (JTV519) inhibits the Ca2+ leak by correcting the defective interdomain interaction. In the present report, we identified the K201-binding domain and characterized the role of this novel domain in the regulation of the RyR2 channel. METHODS AND
RESULTS: An assay using a quartz-crystal microbalance technique (a very sensitive mass-measuring technique) revealed that K201 specifically bound to recombinant RyR2 fragments 1741 to 2270 and 1981 to 2520 but not to other RyR2 fragments from the 1 to 2750 region (1 to 610, 494 to 1000, 741 to 1260, 985 to 1503, 1245 to 1768, 2234 to 2750). By further analysis of the fragment(1741-2270), K201 was found to specifically bind to its subfragment(2114-2149). With the use of the peptide matching this subfragment (DP(2114-2149)) as a carrier, the RyR2 was fluorescently labeled with methylcoumarin acetate (MCA) in a site-directed manner. After tryptic digestion, the major MCA-labeled fragment of RyR2 (155 kDa) was detected by an antibody raised against the central region (Ab(2132)). Moreover, of several recombinant RyR2 fragments, only fragment(2234-2750) was specifically MCA labeled; this suggests that the K201-binding domain(2114-2149) binds with domain(2234-2750). Addition of DP(2114-2149) to the MCA-labeled sarcoplasmic reticulum interfered with the interaction between domain(2114-2149) and domain(2234-2750), causing domain unzipping, as evidenced by an increased accessibility of the bound MCA to a large-size fluorescence quencher. In failing cardiomyocytes, the frequency of spontaneous Ca2+ spark was markedly increased compared with normal cardiomyocytes, whereas incorporation of DP(2114-2149) markedly decreased the frequency of spontaneous Ca2+ spark.
CONCLUSIONS: We first identified the K201-binding site as domain(2114-2149) of RyR2. Interruption of the interdomain interaction between the domain(2114-2149) and central domain(2234-2750) seems to mediate stabilization of RyR2 in failing hearts, which may lead to a novel therapeutic strategy against heart failure and perhaps lethal arrhythmia.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18227387     DOI: 10.1161/CIRCULATIONAHA.107.718957

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  31 in total

Review 1.  Inherited calcium channelopathies in the pathophysiology of arrhythmias.

Authors:  Luigi Venetucci; Marco Denegri; Carlo Napolitano; Silvia G Priori
Journal:  Nat Rev Cardiol       Date:  2012-06-26       Impact factor: 32.419

2.  Intracellular translocation of calmodulin and Ca2+/calmodulin-dependent protein kinase II during the development of hypertrophy in neonatal cardiomyocytes.

Authors:  Jaya Pal Gangopadhyay; Noriaki Ikemoto
Journal:  Biochem Biophys Res Commun       Date:  2010-04-28       Impact factor: 3.575

3.  Dissociation of calmodulin from cardiac ryanodine receptor causes aberrant Ca(2+) release in heart failure.

Authors:  Makoto Ono; Masafumi Yano; Akihiro Hino; Takeshi Suetomi; Xiaojuan Xu; Takehisa Susa; Hitoshi Uchinoumi; Hiroki Tateishi; Tetsuro Oda; Shinichi Okuda; Masahiro Doi; Shigeki Kobayashi; Takeshi Yamamoto; Noritaka Koseki; Hiroyuki Kyushiki; Noriaki Ikemoto; Masunori Matsuzaki
Journal:  Cardiovasc Res       Date:  2010-04-13       Impact factor: 10.787

Review 4.  Targeting ryanodine receptors for anti-arrhythmic therapy.

Authors:  Mark D McCauley; Xander H T Wehrens
Journal:  Acta Pharmacol Sin       Date:  2011-06       Impact factor: 6.150

5.  Aberrant interaction of calmodulin with the ryanodine receptor develops hypertrophy in the neonatal cardiomyocyte.

Authors:  Jaya P Gangopadhyay; Noriaki Ikemoto
Journal:  Biochem J       Date:  2011-09-01       Impact factor: 3.857

6.  Defective domain-domain interactions within the ryanodine receptor as a critical cause of diastolic Ca2+ leak in failing hearts.

Authors:  Hiroki Tateishi; Masafumi Yano; Mamoru Mochizuki; Takeshi Suetomi; Makoto Ono; Xiaojuan Xu; Hitoshi Uchinoumi; Shinichi Okuda; Tetsuro Oda; Shigeki Kobayashi; Takeshi Yamamoto; Yasuhiro Ikeda; Tomoko Ohkusa; Noriaki Ikemoto; Masunori Matsuzaki
Journal:  Cardiovasc Res       Date:  2008-11-07       Impact factor: 10.787

7.  Adrenergic regulation of cardiac contractility does not involve phosphorylation of the cardiac ryanodine receptor at serine 2808.

Authors:  Scott M MacDonnell; Gerardo García-Rivas; Joseph A Scherman; Hajime Kubo; Xiongwen Chen; Héctor Valdivia; Steven R Houser
Journal:  Circ Res       Date:  2008-04-03       Impact factor: 17.367

8.  Defective regulation of the ryanodine receptor induces hypertrophy in cardiomyocytes.

Authors:  Tomoyo Hamada; Jaya P Gangopadhyay; Adel Mandl; Peter Erhardt; Noriaki Ikemoto
Journal:  Biochem Biophys Res Commun       Date:  2009-01-29       Impact factor: 3.575

9.  K201 improves aspects of the contractile performance of human failing myocardium via reduction in Ca2+ leak from the sarcoplasmic reticulum.

Authors:  Karl Toischer; Stephan E Lehnart; Gero Tenderich; Hendrik Milting; Reiner Körfer; Jan D Schmitto; Friedrich A Schöndube; Noboru Kaneko; Christopher M Loughrey; Godfrey L Smith; Gerd Hasenfuss; Tim Seidler
Journal:  Basic Res Cardiol       Date:  2009-08-30       Impact factor: 17.165

Review 10.  Pharmacological characteristics and clinical applications of K201.

Authors:  Noboru Kaneko; Ryuko Matsuda; Yoshihito Hata; Ken Shimamoto
Journal:  Curr Clin Pharmacol       Date:  2009-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.